tenk.fyi

Kymera Therapeutics, Inc.

KYMRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$39.2M

16.7% YoY

Net Income

-$311.4M

39.1% YoY

EPS

$-3.69

23.8% YoY

Cash

$357.0M

196.9% YoY

FY 2025 · As of 2025-12-31